نتایج جستجو برای: β adrenoceptor

تعداد نتایج: 182740  

2008
Thomas D Giles

The classifi cation of αand β-adrenoceptors by Ahlquist and colleagues in 1948 provided the foundation for the development of drugs that could modulate the sympathetic nervous system (SNS) [1]. The fi rst β-blocker, pronethalol, developed by Sir James Black, was limited clinically due to safety concerns. However, the subsequent development of its successor, propranolol, earned Black the Nobel P...

2015
S.N. El-Zohairy M.A. Oriowo C.I. Ezeamuzie

OBJECTIVE Our investigation was designed to examine the signaling pathway involved in the enhancement of vascular endothelial growth factor (VEGF) release by β-adrenoceptor agonists. MATERIALS AND METHODS Human U937 cells differentiated into macrophages were primed with lipopolysaccharide (LPS) in the absence or presence of β-adrenoceptor agonists and antagonists. The VEGF released and the in...

Journal: :Planta medica 2016
Luciana Souza Guzzo Marina Gomes Miranda E Castor Andrea de Castro Perez Igor Dimitri Gama Duarte Thiago Roberto Lima Romero

Cafestol and kahweol are diterpenes found only in the non-saponified lipid fraction of coffee. They are released during boiling and retained in the filtration process. Previous studies have shown peripheral antinociception induced by endogenous opioid peptides released by these diterpenes. Considering that the activation of the opioid system leads to a noradrenaline release, the aim of this stu...

2017
Jillian G. Baker Sheila M. Gardiner Jeanette Woolard Christophe Fromont Gopal P. Jadhav Shailesh N. Mistry Kevin S. J. Thompson Barrie Kellam Stephen J. Hill Peter M. Fischer

β-Blockers reduce mortality and improve symptoms in people with heart disease; however, current clinically available β-blockers have poor selectivity for the cardiac β1-adrenoceptor (AR) over the lung β2-AR. Unwanted β2-blockade risks causing life-threatening bronchospasm and reduced efficacy of β2-agonist emergency rescue therapy. Thus, current life-prolonging β-blockers are contraindicated in...

2014
M T Silva L A Wensing P C Brum N O Câmara E H Miyabara

AIMS β2-adrenergic stimulation causes beneficial effects on structure and function of regenerating muscles; thus, the β2-adrenoceptor may play an important role in the muscle regenerative process. Here, we investigated the role of the β2 -adrenoceptor in skeletal muscle regeneration. METHODS Tibialis anterior (TA) muscles from β2-adrenoceptor knockout (β2 KO) mice were cryolesioned and analys...

2015
Raphael C Anakwue Basden J Onwubere Vincent Ikeh Benedict Anisiuba Samuel Ike Angel-Mary C Anakwue

INTRODUCTION Thyrotoxicosis is an endocrine disorder with prominent cardiovascular manifestations. Thyroid hormone acts through genomic and non-genomic mechanisms to regulate cardiac function. Echocardiography is a useful, non-invasive, easily accessible, and affordable tool for studying the structural and physiological function of the heart. AIM We studied thyrotoxicosis patients in a Nigeri...

2016
Maggie Lam Simon G. Royce Chantal Donovan Maria Jelinic Laura J. Parry Chrishan S. Samuel Jane E. Bourke

Treatment with β-adrenoceptor agonists does not fully overcome the symptoms associated with severe asthma. Serelaxin elicits potent uterine and vascular relaxation via its cognate receptor, RXFP1, and nitric oxide (NO) signaling, and is being clinically evaluated for the treatment of acute heart failure. However, its direct bronchodilator efficacy has yet to be explored. Tracheal rings were pre...

Journal: :European Journal of Pharmacology 2021

Metabolic syndrome is linked to an increased risk of cardiovascular complications by a mechanism involving mainly decreased nitric oxide (NO) bioavailability and impaired NO-soluble guanylate cyclase (sGC)- cyclic guanosine monophosphate (cGMP) signalling (NO-sGC-cGMP). To further develop this scientific point, study aimed investigate the effects long-term treatment with BAY 41–2272 (a sGC stim...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید